Detalhe da pesquisa
1.
Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer.
Cancer Causes Control
; 33(6): 831-841, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384527
2.
Endometrial cancer presentation is associated with social determinants of health in a public healthcare system: A population-based cohort study.
Gynecol Oncol
; 158(1): 130-136, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32354470
3.
Early initiation of palliative care is associated with reduced late-life acute-hospital use: A population-based retrospective cohort study.
Palliat Med
; 33(2): 150-159, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501459
4.
Triple-negative breast cancer prevalence in Africa: a systematic review and meta-analysis.
BMJ Open
; 12(5): e055735, 2022 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35623750
5.
Stopping rules employing response rates, time to progression, and early progressive disease for phase II oncology trials.
BMC Med Res Methodol
; 11: 164, 2011 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22151297
6.
A comparison of a new multinomial stopping rule with stopping rules of fleming and gehan in single arm phase II cancer clinical trials.
BMC Med Res Methodol
; 11: 95, 2011 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21693051
7.
Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.
NPJ Breast Cancer
; 7(1): 90, 2021 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34238931
8.
Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 7(4): 534-542, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538782
9.
Selecting Patients for Oncotype DX Testing Using Standard Clinicopathologic Information.
Clin Breast Cancer
; 20(1): 61-67, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31551182
10.
Comparison of outcomes of phase II studies and subsequent randomized control studies using identical chemotherapeutic regimens.
J Clin Oncol
; 23(28): 6982-91, 2005 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16192585
11.
Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer.
Can J Urol
; 13 Suppl 2: 2-10, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16672122
12.
Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial.
J Geriatr Oncol
; 5(2): 119-26, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24495703
13.
Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.
Eur Urol
; 59(4): 556-62, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21190791
14.
Making sense of prostate specific antigen: improving its predictive value in patients undergoing prostate biopsy.
J Urol
; 175(2): 489-94, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16406978